BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2558930)

  • 41. Early effects of parathyroid hormone on membrane potential of rat osteoblasts in culture: role of cAMP and Ca2+.
    Fritsch J; Edelman A; Balsan S
    J Bone Miner Res; 1988 Oct; 3(5):547-54. PubMed ID: 2461641
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of synthetic bovine parathyroid hormone (1-34) and its analogues on 45Ca uptake and adenylate cyclase activation in bone and plasma calcium levels in the chick.
    Dacke CG; Shaw AJ
    Q J Exp Physiol; 1988 Jul; 73(4):573-84. PubMed ID: 3174916
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Study of the mechanisms involved in the vasorelaxation induced by (-)-epigallocatechin-3-gallate in rat aorta.
    Alvarez E; Campos-Toimil M; Justiniano-Basaran H; Lugnier C; Orallo F
    Br J Pharmacol; 2006 Feb; 147(3):269-80. PubMed ID: 16299547
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mechanisms of PTH-induced rise in cytosolic calcium in adult rat hepatocytes.
    Klin M; Smogorzewski M; Khilnani H; Michnowska M; Massry SG
    Am J Physiol; 1994 Nov; 267(5 Pt 1):G754-63. PubMed ID: 7977736
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibitory effects of forskolin on vascular smooth muscle of rabbit aorta.
    Abe A; Karaki H
    Jpn J Pharmacol; 1988 Mar; 46(3):293-301. PubMed ID: 2837603
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypotensive action of synthetic fragments of parathyroid hormone.
    Pang PK; Yang MC; Tenner TE; Chang JK; Shimizu M
    J Pharmacol Exp Ther; 1981 Mar; 216(3):567-71. PubMed ID: 7205637
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Study of the in vivo and in vitro cardiovascular effects of (+)-glaucine and N-carbethoxysecoglaucine in rats.
    Orallo F; Fernández Alzueta A; Campos-Toimil M; Calleja JM
    Br J Pharmacol; 1995 Apr; 114(7):1419-27. PubMed ID: 7606346
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacological dissection of Ca2+ channels in the rat aorta by Ca2+ entry modulators.
    Rico I; Alonso MJ; Salaices M; Marín J
    Pharmacology; 1990; 40(6):330-42. PubMed ID: 1700444
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanisms underlying the inhibitory effect of dibutyryl cyclic AMP in vascular smooth muscle.
    Abe A; Karaki H
    Eur J Pharmacol; 1992 Feb; 211(3):305-11. PubMed ID: 1319910
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of parathyroid hormone and the synthetic 1-34 amino-terminal fragment in rats and dogs.
    Stevenson RW; Parsons JA
    J Endocrinol; 1983 Apr; 97(1):21-30. PubMed ID: 6842124
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prostaglandin-stimulated second messenger signaling in bone-derived endothelial cells is dependent on confluency in culture.
    Ida R; Lee A; Huang J; Brandi ML; Yamaguchi DT
    J Cell Physiol; 1994 Sep; 160(3):585-95. PubMed ID: 8077296
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The arterio-venous difference for immunoreactive parathyroid hormone and the production of adenosine 3,'5'-monophosphate by isolated perfused bone: studies with analogs of parathyroid hormone.
    Martin KJ; Bellorin-Font E; Freitag J; Rosenblatt M; Slatopolsky E
    Endocrinology; 1981 Sep; 109(3):956-9. PubMed ID: 6266817
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rapid development of renal resistance to low doses of synthetic bovine parathyroid hormone fragment 1-34. Dissociation of urinary cyclic adenosine monophosphate, phosphaturic, and calciuric responses.
    Law WM; Heath H
    J Clin Invest; 1983 Sep; 72(3):1106-13. PubMed ID: 6309905
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vasodilation of the rat mesenteric vasculature by parathyroid hormone.
    Nickols GA; Metz MA; Cline WH
    J Pharmacol Exp Ther; 1986 Feb; 236(2):419-23. PubMed ID: 2418196
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vasodilator effects of quercetin in isolated rat vascular smooth muscle.
    Duarte J; Pérez-Vizcaíno F; Zarzuelo A; Jiménez J; Tamargo J
    Eur J Pharmacol; 1993 Aug; 239(1-3):1-7. PubMed ID: 8223884
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structural prerequisites for the hypotensive action of parathyroid hormone.
    Ellison DH; McCarron DA
    Am J Physiol; 1984 May; 246(5 Pt 2):F551-6. PubMed ID: 6720960
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ryanodine reveals multiple contractile and relaxant mechanisms in vascular smooth muscle: simultaneous measurements of mechanical activity and of cytoplasmic free Ca2+ level with fura-2.
    Hisayama T; Takayanagi I; Okamoto Y
    Br J Pharmacol; 1990 Aug; 100(4):677-84. PubMed ID: 2119840
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Desensitization of rat osteoblast-like cells (ROS 17/2.8) to parathyroid hormone uncouples the adenosine 3',5'-monophosphate and cytosolic ionized calcium response limbs.
    Bidwell JP; Fryer MJ; Firek AF; Donahue HJ; Heath H
    Endocrinology; 1991 Feb; 128(2):1021-8. PubMed ID: 1846574
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of 8-bromo cyclic GMP and verapamil on depolarization-evoked Ca2+ signal and contraction in rat aorta.
    Salomone S; Morel N; Godfraind T
    Br J Pharmacol; 1995 Apr; 114(8):1731-7. PubMed ID: 7599942
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hemodynamic effects of bPTH(1-34) and its analogue Nle8,18Tyr34bPTH(3-34) amide.
    Daugirdas JT; Al-Kudsi RR; Ing TS; Yang MC; Leehey DJ; Pang PK
    Miner Electrolyte Metab; 1987; 13(1):33-7. PubMed ID: 3587182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.